Straits Research has released its latest report on the NGS-based RNA-Sequencing Market, providing a comprehensive analysis of the industry’s trajectory. The report states that the market was valued at USD XX Billion in 2023 and is projected to grow from USD XX Billion in 2024 to USD XX Billion by 2032, expanding at an impressive CAGR of 19.4% during the forecast period (2024-2032).
For a full PDF sample copy of the report, visit: https://straitsresearch.com/report/ngs-based-rna-sequencing-market/request-sample
Market Drivers
The NGS-based RNA-Sequencing Market is experiencing exponential growth due to various factors, including:
- Increasing Adoption of Next-Generation Sequencing (NGS) Technologies – Rapid advancements in sequencing technology are making RNA sequencing more efficient and cost-effective.
- Expanding Applications in Medical and Pharmaceutical Research – NGS-based RNA sequencing is being widely used in drug discovery, biomarker identification, and personalized medicine.
- Growing Investments in Genomics and Precision Medicine – Governments and private organizations are heavily investing in genomic research, further propelling the market.
- Technological Innovations and Automation in Sequencing Platforms – Emerging technologies are streamlining sequencing processes and improving data accuracy.
- Rising Prevalence of Genetic Disorders and Cancer Research – The growing need for early disease detection and targeted therapies is increasing demand for RNA sequencing.
Key Developments in the NGS-based RNA-Sequencing Market
The report highlights key advancements in the market, including:
- Development of innovative sequencing platforms.
- Collaborations between research institutions and biotechnology firms.
- Introduction of cost-efficient sequencing solutions.
- Expansion of service offerings by major market players.
- Increased regulatory approvals for sequencing applications in healthcare.
Top Key Players
Leading companies operating in the NGS-based RNA-Sequencing Market include:
- Illumina (U.S.)
- Thermo Fisher Scientific (U.S.)
- Oxford Nanopore
- Agilent Technologies, Inc. (U.S.)
- BGI (China)
- PerkinElmer Inc. (U.S.)
- QIAGEN (Germany)
- Eurofins Scientific (Luxembourg)
- Hoffmann-La Roche Ltd (Switzerland)
- Takara Bio Inc. (Japan)
- Tecan Genomics, Inc. (Switzerland)
For detailed segmentation insights, visit: https://straitsresearch.com/report/ngs-based-rna-sequencing-market/segmentation
Segmentation Analysis of the NGS-based RNA-Sequencing Market
The market is categorized based on product and service, technology, application, and end-user.
By Product and Service
- Sample Preparation Products
- Sequencing Platforms and Consumables
- Sequencing Services
- Data Analysis, Storage, and Management
By Technology
- Sequencing by Synthesis (SBS)
- Ion Semiconductor Sequencing
- Single-molecule Real-time Sequencing (SMRT)
- Nanopore Sequencing
By Application
- Expression Profiling Analysis
- Small RNA Sequencing
- De Novo Transcriptome Assembly
- Variant Calling and Transcriptome Epigenetics
By End-User
- Research and Academia
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
Future Prospects and Industry Outlook
With the increasing integration of artificial intelligence (AI) and machine learning (ML) in genomic analysis, the market is expected to witness further innovations in data processing and result accuracy. Additionally, the expansion of sequencing applications in personalized medicine and agriculture is likely to create new growth avenues for market participants.
For More Information or Customization Before Buying, Visit: https://straitsresearch.com/buy-now/ngs-based-rna-sequencing-market
About Straits Research
Straits Research is a leading provider of business intelligence solutions, specializing in market research, analytics, and advisory services. The firm delivers in-depth insights through comprehensive reports, assisting businesses in making informed strategic decisions.
Contact Us
Straits Research
Email: sales@straitsresearch.com
Address: 825 3rd Avenue, New York, NY, USA, 10022
Phone: +1 646 905 0080 (US), +91 8087085354 (India), +44 203 695 0070 (UK)
